Concepedia

Ben Klünder

BK

Statistics

Publications

4

Citations

123

H-Index

4

Active since

2018

Affiliations

AbbVie (United States)(Current)

Ben Klünder is an author at AbbVie (United States) specializing in osteoarthritis, rheumatology, and inflammatory arthritis.

Top concepts

Publications per year

2018–2019

4

Publications

4

Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I–III Clinical Trials

Ben Klünder, Rajendar K. Mittapalli, Mohamed‐Eslam F. Mohamed et al. · Clinical Pharmacokinetics · 2019 · 59 citations · Full text

Exposure–response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis

Amit Khatri, Ben Klünder, Paul M. Peloso et al. · Lara D. Veeken · 2018 · 24 citations

Exposure–Response Analyses for Upadacitinib Efficacy and Safety in the Crohn's Disease CELEST Study and Bridging to the Extended‐Release Formulation

Mohamed‐Eslam F. Mohamed, Ben Klünder, Ana P. Lacerda et al. · Clinical Pharmacology & Therapeutics · 2019 · 21 citations · Full text

Exposure–Response Analyses of Upadacitinib Efficacy in Phase II Trials in Rheumatoid Arthritis and Basis for Phase III Dose Selection

Mohamed‐Eslam F. Mohamed, Ben Klünder, Heidi S. Camp et al. · Clinical Pharmacology & Therapeutics · 2019 · 19 citations · Full text

, , +14

Rows per page

1–4 of 4